In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an infectious disease that has spread worldwide. Current treatments are limited in both availability and efficacy, such that improving our understanding of the factors that facilitate infection is urgently needed to more effectively tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Amruta, Narayanappa, Engler-Chiurazzi, Elizabeth B., Murray-Brown, Isabel C., Gressett, Timothy E., Biose, Ifechukwude J., Chastain, Wesley H., Befeler, Jaime B., Bix, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352850/
https://www.ncbi.nlm.nih.gov/pubmed/34389403
http://dx.doi.org/10.1016/j.lfs.2021.119881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352850/
https://www.ncbi.nlm.nih.gov/pubmed/34389403
http://dx.doi.org/10.1016/j.lfs.2021.119881

Ejemplares similares